Mark J. Sarnak

Featured in: Favicon

nature.com Favicon

acpjournals.org Favicon

theclinics.com Favicon

cardiology.theclinics.com

Articles

Vadadustat for Treatment of Anemia in Patients With Dialysis-Dependent Chronic Kidney Disease Receiving Peritoneal Dialysis

Dec 4, 2024 | digitalcommons.library.tmc.edu | Mark J. Sarnak |Rajiv Agarwal |Neil Boudville |Kai-Uwe Eckardt

BACKGROUND: Hypoxia-inducible factor prolyl hydroxylase inhibitors such as vadadustat may provide an oral alternative to injectable erythropoiesis-stimulating agents for treating anemia in patients receiving peritoneal dialysis.

Contact details

Emails

[email protected]

Socials & Sites

Try JournoFinder For Free

Search and contact over 1M+ journalist profiles, browse 100M+ articles, and unlock powerful PR tools.

Start Your 7-Day Free Trial →